Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 and Letrozole in Obese ER+ Breast Cancer
NCT02538484Phase 1Completed
- Sponsor
- UT Health San Antonio
- Start
- Apr 2016
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in breast cancer (3 arms), sponsored by UT Health San Antonio. Primary endpoints: Change in levels of aromatase target gene at 30 days and Change in serum levels of PGE2 at 30 days. Started Apr 2016; status: completed.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02538484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02538484.